Medtech
Use of innovative technology in the treatment of brain tumor patients, now also in Zwickau, the central treatment center in East Germany.
Columbia, SC – Obsidio, Inc., a pre-clinical stage medical materials developer pioneering a universal embolic hydrogel designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion, announced the formation of its clinical advisory board.
MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel.
Beyond Air, Inc. announced an exclusive five-year global supply agreement for NO and NO2 calibration gas with MESA Specialty Gases & Equipment.
New research report estimates near-term market opportunity for emerging biosimilar markets, and examines role of drug delivery device design in competitive differentiation
A new Atrial Fibrillation Management Report highlights that catheter ablation is almost 10 times more effective at delaying Atrial Fibrillation progression than drug therapy, yet just 4% of eligible patients are receiving ablation therapy
Company recently received FDA approval for clinical trial; next generation device, SonoCloud-9, will soon be trialed in US
It was a busy week for clinical trial announcements. Here’s a look.
Strategic investment in the US-based company complements Advanced MedTech’s non-invasive product portfolio and strengthens its leadership in urology and stone management
Miles D. White will step down from his role as CEO following 21 years with the company. He will be succeeded by another long-time Abbott veteran, Robert B. Ford, who has been with the company for 23 years.
PRESS RELEASES